Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.
FDA establishment 1000568184, London, United Kingdom. Part of A. Nelson & Co.'s FDA records. Every inspection FDA has posted for the site, with its outcome and cited regulations, and the shipments FDA refused at the border.
Inspections: 6
Official action indicated: 2
Form 483s posted: 1
Warning letters: 1
Import refusals since 2014: 24
Inspections by fiscal year
FY2018 to FY2027 to date; 1 classified OAI
How to read this
A hatched bar is a year that is not over, so its count covers only part of the year.
21 CFR 211.22(a). Approve or reject components, products The quality control unit lacks the responsibility and authority to approve and reject all labeling.
21 CFR 211.198(a). Quality Control Review Complaint procedures are deficient in that they do not include provisions that allow for the review and determination of an investigation by the quality control unit.
21 CFR 211.67(a). Cleaning / Sanitizing / Maintenance Equipment and utensils are not cleaned, maintained, and sanitized at appropriate intervals to prevent malfunctions and contamination that would alter the safety, identity, strength, quality or purity of the drug product.
21 CFR 211.25(a). Training , Education , Experience overall Employees engaged in the manufacture, processing, packing, and holding of a drug product lack the training required to perform their assigned functions.
21 CFR 211.125(a). Strict control not exercised over labeling issued Strict control is not exercised over labeling issued for use in drug product labeling operations.
21 CFR 211.160(b). Scientifically sound laboratory controls Laboratory controls do not include the establishment of scientifically sound and appropriate test procedures designed to assure that components, drug product containers, closures, in-process materials, and drug products conform to appropriate standards of identity, strength, quality and purity.
21 CFR 211.160(b)(1). Samples (various types) representative, identified properly Samples taken to determine conformance to appropriate written specifications for the acceptance of each lot within each shipment of components are not representative.
21 CFR 211.182. Written records kept in individual logs Written records of major equipment use are not included in individual equipment logs.
Voluntary Action Indicated (VAI)
Nov 14, 2011
Drugs · Drug Quality Assurance
None posted
Official Action Indicated (OAI)
Form 483 observations
What FDA investigators wrote up at the end of an inspection, from the 483s FDA posted; newest first
Failure to establish appropriate microbial specifications for homeopathic product, in accordance with accepted standards and consistent with the manufacturing process.
Written records of investigations into unexplained discrepancies do not always include the conclusion and follow-up.
Document control procedures under Quality Unit oversight are inadequate.
Your firm failed to establish adequate written procedures for production and process controls designed to assure that the drug products have the identity, strength, purity, and quality that they are purported or represented to possess.
Complaint investigations under Quality Unit oversight are inadequate.
Warning letters
Letters naming this establishment; each opens the letter
An FEI (FDA Establishment Identifier) names one physical site. Inspections, outcomes and citations come from FDA's Data Dashboard; FDA posts citations only for some inspections. Recalls come from FDA's enforcement reports (iRES), one row per recall even when it covers many lots. A contract site can make products for many companies, so the company shown is the one FDA lists as the site's firm. Form 483 observations are read by Arca from the 483s FDA posts in its FOIA reading room, most of them scans: the first sentence of each observation, with redactions as FDA made them. FDA posts 483s for a minority of inspections.FDA Data Dashboard, warning letters and enforcement reports